Enhancement of Absorption of Insulin-Loaded Polyisobutylcyanoacrylate Nanospheres by Sodium Cholate After Oral and Subcutaneous Administration in Diabetic Rats

REFERENCES

• Lee V. H.L., Yamamoto A. Penetration and Enzymatic Barriers to Peptide and Protein Absorption. Adv. Drug Delivery Rev. 1990; 4: 171–207
   Google Scholar
• Lee H. J. Biopharmaceutical Properties and Pharmacokinetics of Peptide Drugs. Peptide-Based Drug Design, M. Taylor, G. Amidon. American Chemical Society, Washington, DC 1995; 69–97
   Google Scholar
• Yamamoto A., Taniguchi T., Rikyuu K., Tsuji T., Fujita T., Murakami M., Muranishi S. Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in Rats. Pharm. Res. 1994; 11(10)1496–1500
   PubMed Web of Science ®Google Scholar
• Yamamoto A., Umemori S., Muranishi S. Absorption Enhancement of Intrapulmonary Administered Insulin by Various Absorption Enhancers and Protease Inhibitors in Rats. J. Pharm. Pharmacol. 1994; 46: 14–18
   PubMed Web of Science ®Google Scholar
• Bai J. P., Chang L. L. Effects of Enzyme Inhibitors and Insulin Concentration on Transepithelial Transport of Insulin in Rats. J. Pharm. Pharmacol. 1996; 48(10)1078–1082
   PubMed Web of Science ®Google Scholar
• Muranishi S. Absorption Enhancers. Crit. Rev. Ther. Drug Carrier Syst. 1990; 7: 1–33
   PubMed Web of Science ®Google Scholar
• Scott-Moncrieff J. C., Shao Z., Mitra A. K. Enhancement of Intestinal Insulin Absorption by Bile Salt–Fatty Acid Mixed Micelles in Dogs. J. Pharm. Sci. 1994; 83(10)1465–1469
   PubMed Web of Science ®Google Scholar
• Morishita M., Morishita I., Takayama K., Machida Y., Nagai T. Site-Dependent Effect of Aprotinin, Sodium Caprate, Na2EDTA and Sodium Glycocholate on Intestinal Absorption of Insulin. Biol. Pharm. Bull. 1993; 16: 68–72
   PubMed Web of Science ®Google Scholar
• Shao Z., Li Y., Chermak T., Mitra A. K. Cyclodextrins as Mucosal Absorption Promoters of Insulin. II. Effects of Beta-Cyclodextrin Derivatives on Alpha-Chymotryptic Degradation and Enternal Absorption of Insulin in Rats. Pharm. Res. 1994; 11(8)1174–1179
   PubMed Web of Science ®Google Scholar
• Asada H., Douen T., Waki M., Adachi S., Fujita T., Yamamoto A., Muranishi S. Absorption Characteristics of Chemically Modified-Insulin Derivatives with Various Fatty Acids in the Small and Large Intestine. J. Pharm. Sci. 1995; 84: 682–687
   PubMed Web of Science ®Google Scholar
• Hashizume M., Douen T., Murakami M., Yamamoto A., Takada K., Muranishi S. Improvement of Large Intestinal Absorption of Insulin by Chemical Modification with Palmitic Acid in Rats. J. Pharm. Pharmacol. 1992; 44(7)555–559
   PubMed Web of Science ®Google Scholar
• Hosny E. A., Ghilzai N. M., Elmazar M. M. Promotion of Oral Insulin Absorption in Diabetic Rabbits Using pH-Dependent Coated Capsules Containing Sodium Cholate. Pharm. Acta Helv. 1997; 72(4)203–207
   PubMedGoogle Scholar
• Suzuki A., Morishita M., Kajita M., Takayama K., Isowa K., Chiba Y., Tokiwa S., Nagai T. Enhanced Colonic and Rectal Absorption of Insulin Using a Multiple Emulsion Containing Eicosapentaenoic Acid and Docosahexaenoic Acid. J. Pharm. Sci. 1998; 87(10)1196–1202
   PubMed Web of Science ®Google Scholar
• Spangler R. S. Insulin Administration via Liposomes. Diabetes Care 1990; 19(9)911–922
   Google Scholar
• Donbrow M. Microcapsules and Nanoparticles in Medicine and Pharmacy. CRC Press, Boca Raton, FL 1991
   Google Scholar
• Chavany C., Le Doan T., Couvreur P., Puisieux F., Helene C. Polyalkylcyanoacrylate Nanoparticles as Polymeric Carriers for Antisense Oligonuleotides. Pharm. Res. 1992; 9: 441–449
   PubMed Web of Science ®Google Scholar
• Couvreur P., Kante B., Roland M., Guiot P., Bauduin P., Speiser P. Polycyanoacrylate Nanoparticles as Potential Lysomotropic Carriers: Preparation, Morphological and Sorptive Properties. J. Pharm. Pharmacol. 1979; 31: 311–332
   Web of Science ®Google Scholar
• Guiot P., Couvreur P. Polymeric Nanoparticles and Microspheres. CRC Press, Boca Raton, FL 1986
   Google Scholar
• Guise V., Drouin J. Y., Benoit J., Mahulean J., Dumint P., Couvreur P. Vidarabin-Loaded Nanoparticles: A Physicochemical Study. Pharm. Res. 1990; 7: 736–741
   PubMed Web of Science ®Google Scholar
• Radwan M. A. In Vitro Evaluation of Polyisobutylcyanoacrylate Nanoparticles as a Controlled Drug Delivery System of Theophylline. Drug Dev. Ind. Pharm. 1995; 21(20)2371–2375
   Web of Science ®Google Scholar
• Radwan M. A., Aly Z. H., Zaghloul I. Y. In Vivo Performance of Parenteral Theophylline-Loaded Polyisobutylcyanoacrylate Nanoparticles in Rats. Eur. J. Pharm. Sci. 1999; 8: 95–98
   PubMed Web of Science ®Google Scholar
• Damge C., Michel C., Aprahamian M., Couvreur P. New Approach for Oral Administration of Insulin Polyalkylcyanoacrylate Nanocapsules as Drug Carrier. Diabetes 1988; 37: 246–251
   PubMed Web of Science ®Google Scholar
• Damge C., Michel C., Aprahamian M., Couvreur P., Devissaguet J. P. Nanocapsules as Carriers for Oral Peptide Delivery. J. Controlled Release 1990; 13: 233–239
   Web of Science ®Google Scholar
• Lowe P. J., Temple C. S. Calcitonin and Insulin in Isobutylcyanoacrylate Nanospheres: Protection Against Proteases and Effect on Intestinal Absorption in Rats. J. Pharm. Pharmacol. 1994; 46(7)547–552
   PubMed Web of Science ®Google Scholar
• Damge C., Vonderscher J., Marbach P., Pinget M. Poly(alkyl Cyanoacrylate) Nanospheres as a Delivery System in the Rat for Octreotide, a Long-Acting Somatostatin Analogue. J. Pharm. Pharmacol. 1997; 49(10)949–954
   PubMed Web of Science ®Google Scholar
• Damge C., Vranckx H., Balschmidt P., Couvreur P. Poly(alkyl Cyanoacrylate) Nanospheres for Oral Administration of Insulin. J. Pharm. Sci. 1997; 86(12)1403–1409
   PubMed Web of Science ®Google Scholar
• Aboubakar M., Puisieux F., Couvreur P., Vauthier C. Physico-chemical Characterization of Insulin-Loaded Poly(isobutylcyanoacrylate) Nanocapsules Obtained by Interfacial Polymerization. Int. J. Pharm. 1999; 183: 63–66
   PubMed Web of Science ®Google Scholar
• Aboubakar M., Puisieux F., Couvreur P., Deyme M., Vauthier C. Study of the Mechanism of Insulin Encapsulated in Poly(isobutylcyano- acrylate) Nanocapsules Obtained by Interfacial Polymeriza-tion. J. Biomed. Mater. Res. 1999; 47: 568–576
   PubMed Web of Science ®Google Scholar
• Michel C., Aprahamian M., Defontaine L., Couvreur P., Damge C. The Effect of Site of Administration in the Gastrointestinal Tract on the Absorption of Insulin from Nanocapsules in Diabetic Rats. J. Pharm. Pharmacol. 1991; 43: 1–5
   PubMed Web of Science ®Google Scholar
• Hirai S., Yashiki T., Mima H. Mechanisms for the Enhancement of the Nasal Absorption of Insulin by Surfactants. Int. J. Pharm. 1981; 9: 173–184
   Web of Science ®Google Scholar
• Ziv E., Lior O., Kidron M. Absorption of Protein via the Intestinal Wall. A Quantitative Model. Biochem. Pharmacol. 1987; 36: 1035–1039
   PubMed Web of Science ®Google Scholar